More to Explore: Further Definition of Risk Factors for COPD - Differential Gender Difference, Modest Elevation in PM2.5, and e-Cigarette Use

被引:13
作者
Zhang, Yixuan [1 ]
Wang, Lu [2 ]
Mutlu, Gokhan M. [3 ]
Cai, Hua [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med, Dept Anesthesiol,Div Cardiol,Dept Med, Los Angeles, CA 90095 USA
[2] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Pulm & Crit Care Med, Hangzhou, Peoples R China
[3] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave, Chicago, IL 60637 USA
关键词
Chronic obstructive pulmonary disease (COPD); risk factors; cigarette smoking; environmental pollution; gender difference; modest elevation in PM2; 5; e-cigarettes; OBSTRUCTIVE PULMONARY-DISEASE; TOBACCO PRODUCT USE; HIGH-SCHOOL-STUDENTS; AMBIENT PARTICULATE MATTER; HOUSEHOLD AIR-POLLUTION; UNITED-STATES; ELECTRONIC CIGARETTES; OXIDATIVE STRESS; NEVER-SMOKERS; SMOKING-CESSATION;
D O I
10.3389/fphys.2021.669152
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Chronic obstructive pulmonary disease (COPD) is a severe respiratory disease with high morbidity and mortality, representing the third leading cause of death worldwide. Traditional risk factors for COPD include aging, genetic predisposition, cigarette smoking, exposure to environmental pollutes, occupational exposure, and individual or parental respiratory disease history. In addition, latest studies have revealed novel and emerging risk factors. In this review, differential gender difference as a factor for COPD development at different territories is discussed for the first time. First, women seem to have more COPD, while more women die of COPD or have more severe COPD, in Western societies. This seems different from the impression that COPD dominants in men, which is true in Eastern societies. It might be related to higher rate of cigarette smoking in women in developed countries (i.e., 12.0% of women in United States smoke vs. 2.2% in China). Nonetheless, women in Eastern societies are exposed to more biomass usage. Second, modest elevation in PM2.(5) levels at >similar to 21.4-32.7 mu g/m(3), previously considered "cleaner air," is associated with incidence of COPD, indicating that more stringent goals should be set for the reduction of PM2.(5) levels to prevent COPD development. Last but not least, e-cigarette use, which has become an epidemic especially among adolescents as officially declared by the United States government, has severe adverse effects that may cause development of COPD early in life. Built upon an overview of the established risk factors for COPD primarily focusing on cigarette smoking and environmental pollutions, the present review further discusses novel concepts, mechanisms, and solutions evolved around the emerging risk factors for COPD discussed above, understanding of which would likely enable better intervention of this devastating disease.
引用
收藏
页数:12
相关论文
共 131 条
[1]  
Akinbami Lara J, 2011, NCHS Data Brief, P1
[2]   Combined Impact of Smoking and Early-Life Exposures on Adult Lung Function Trajectories [J].
Allinson, James P. ;
Hardy, Rebecca ;
Donaldson, Gavin C. ;
Shaheen, Seif O. ;
Kuh, Diana ;
Wedzicha, Jadwiga A. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 196 (08) :1021-1030
[3]  
American Lung Association, 2020, LEARN COAL WORK PNEU
[4]  
[Anonymous], 2020, LANCET RESP MED, V8, P935, DOI 10.1016/S2213-2600(20)30419-7
[5]  
[Anonymous], 2019, Household Air Pollution and Health
[6]  
[Anonymous], 2019, Chronic obstructive pulmonary disease (COPD)
[7]  
[Anonymous], 2016, POSTNOTE Number 533
[8]  
[Anonymous], 2019, OUTBREAK LUNG INJURY
[9]   EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY [J].
ANTHONISEN, NR ;
CONNETT, JE ;
KILEY, JP ;
ALTOSE, MD ;
BAILEY, WC ;
BUIST, AS ;
CONWAY, WA ;
ENRIGHT, PL ;
KANNER, RE ;
OHARA, P ;
OWENS, GR ;
SCANLON, PD ;
TASHKIN, DP ;
WISE, RA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19) :1497-1505
[10]   The effects of a smoking cessation intervention on 14.5-year mortality - A randomized clinical trial [J].
Anthonisen, NR ;
Skeans, MA ;
Wise, RA ;
Manfreda, J ;
Kanner, RE ;
Connett, JE .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (04) :233-239